Ken Griffin Lumira Dx LTD Transaction History

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$0.46 - $1.2 $15,788 - $41,186
34,322 New
34,322 $15,000
Q3 2022

Nov 14, 2022
BUY
$0.15 - $3.05 $5,807 - $118,089
38,718 New
38,718 $39,000

Others Institutions Holding LMDX

# of Institutions
3
Shares Held
365K
Call Options Held
0
Put Options Held
0
View Full List

About LumiraDx Ltd

LMDX Quotes by TradingView
  • Ticker LMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 170,688,000
  • Market Cap $1.71M
  • Description
  • LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. It manufactures and commercializes a diagnostic platform that supports various tests with lab comparable performance at the point of care. The compa...
More about LMDX
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email